Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance-Reference-Cited by-同舟云学术

Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance

Published:2017-07 Issue: Volume:239 Page:1-9
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Brenner Bluma G.,Wainberg Mark A.

Funder

Canadian Institutes for Health Research (CIHR)

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference98 articles.

1. Impact of primary elvitegravir resistance-associated mutations in HIV-1 integrase on drug susceptibility and viral replication fitness;Abram;Antimicrob. Agents Chemother.,2013

2. Dolutegravir versus placebo in subjects harbouring HIV-1 with integrase inhibitor resistance associated substitutions: 48-week results from VIKING-4, a randomized study;Akil;Antivir. Ther.,2015

3. HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia;Armenia;J. Antimicrob. Chemother.,2015

4. Identification of novel mutations responsible for resistance to MK-2048, a second-generation HIV-1 integrase inhibitor;Bar-Magen;J. Virol.,2010

5. Dual therapy treatment strategies for the management of patients infected with HIV: a systematic review of current evidence in ARV-naive or ARV-experienced, virologically suppressed patients;Baril;PLoS One,2016

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beware of resistance to 2nd-generation integrase inhibitors: A systematic meta-analysis of HIV-1 integrase inhibitors resistance and drug resistance mutations;International Journal of Antimicrobial Agents;2024-09

2. Postmortem Analysis of Dolutegravir, Tenofovir, Lamivudine, and Efavirenz Penetration in Multiple Central Nervous System Compartments;The Journal of Infectious Diseases;2024-06-20

3. Reverse transcription of HIV-1 2-LTR circle transcripts does frequently cause 3'-polypurine tract mutations implicated in dolutegravir resistance;Journal of Virology;2024-06-13

4. Early Effects of Scaling Up Dolutegravir-Based ARV Regimens Among Children Living with HIV in Malawi;AIDS and Behavior;2024-04-13

5. Reasons, Efficacy and Safety of Switching to Dolutegravir-Based Regimens Among Virologically Suppressed PLWH: A Retrospective Cohort Study of 96 Weeks;Infection and Drug Resistance;2024-04